Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Repligen Corporation RGEN
Healthcare - Medical - Instruments & Supplies - NASDAQ - US
Watchlist
$ 124.73
-12.4 %
$ 6.99 B
Market Cap
-4157.67
P/E
Price Target
Average
55.05%
Revenue Forecast
Estimate
13.24%
EBIT
Estimate
37.66%
Net Income
Estimate
53.74%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Repligen Corporation
Wall Street analysts predict an average 1-year price target for
RGEN
of
$193
, with forecasts ranging from a low of
$155
to a high of
$220
.
RGEN Lowest Price Target
Wall Street Target
155 USD
24.27%
RGEN Average Price Target
Wall Street Target
193 USD
55.05%
RGEN Highest Price Target
Wall Street Target
220 USD
76.38%
REVENUE FORECAST
Revenue Forecast Chart
RGEN
EBIT FORECAST
EBIT Forecast Chart
RGEN
NET INCOME FORECAST
Net Income Chart
RGEN
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan